Our rationale for the IBB trade from 2 weeks ago was more technical than fundamental, as the etf approached the $255 resistance level after a big rally from the mid-April lows. After what looked like …
Continue readingGILD
Biotechs have been a leader throughout the 2009-2014 bull market. The weekly chart of IBB, the biotech ETF, illustrates the incredible run over the past 5 years: The ETF more than quadrupled from early 2009 …
Continue reading
The fallen growth stocks are some of the biggest winners on today’s move higher in the broader market. Internet, biotech, and solar stocks are all outperforming. I wrote about the three sector etfs for these …
Continue reading
Very light options volumes for the second straight day. As high fliers have gotten hit, a lot of the call volume related to those names has dried up. However, even macro ETF options volumes were …
Continue reading
The biotech sector was the talk of the town on Friday. The biotech ETF, IBB, was down almost 5%, and biotech shares led the Nasdaq and the healthcare sector lower. The Big Four, AMGN, GILD, …
Continue reading
Biotechs were a leading sub sector in 2013, and have attracted a lot of attention to start 2014 as a result. In mid-January I highlighted the charts of the “Big Four of Biotech” in a …
Continue reading
Macro ETFs dominated the options volumes on Friday, as stock volumes were the highest in several weeks on month end flows and rebalancing. 1. SPY – Hit a new all-time high before closing close to flat …
Continue readingBiotech has been the leader to start 2014, with ICPT the poster boy for the sector after its 280% advance on Thursday (though down more than 30% today). I wanted to take a quick look …
Continue readingAmgen was one of my favorite large cap stocks early in 2013. For a brief recap of the fundamentals, here is what I wrote about the company in an early March Name That Trade post: …
Continue reading
1. AIG – stock continues to decline, now down 8% since its earnings results last week and now essentially trading at the low from early October. A trader made a fairly large upside bet in …
Continue reading